Literature DB >> 15318583

Do drug benefits help Medicare beneficiaries afford prescribed drugs?

Thomas S Rector1, Patricia J Venus.   

Abstract

We surveyed a random sample of 1,500 elderly people with chronic diseases who were enrolled in eight Medicare+Choice plans with a zero-premium, dollars 200-dollars 300 annual drug benefit and no deductible. An estimated 32 percent did not fill a prescription or reduced a prescribed dosage because of out-of-pocket costs. Lower drug benefits, higher out-of-pocket costs, lower income, and poorer health were associated with underuse of medications. Drug benefits with high out-of-pocket costs might not be effective for beneficiaries who use medications for chronic diseases, especially those with low incomes.

Entities:  

Mesh:

Year:  2004        PMID: 15318583     DOI: 10.1377/hlthaff.23.4.213

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  20 in total

Review 1.  Interventions to promote adherence with oral agents.

Authors:  Susan M Schneider; Kimberly Hess; Tracy Gosselin
Journal:  Semin Oncol Nurs       Date:  2011-05       Impact factor: 2.315

2.  High Out-of-Pocket Medical Spending among the Poor and Elderly in Nine Developed Countries.

Authors:  Katherine Baird
Journal:  Health Serv Res       Date:  2016-01-22       Impact factor: 3.402

3.  How the new medicare drug benefit could affect vulnerable populations.

Authors:  Walid F Gellad; Haiden A Huskamp; Kathryn A Phillips; Jennifer S Haas
Journal:  Health Aff (Millwood)       Date:  2006 Jan-Feb       Impact factor: 6.301

4.  Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study.

Authors:  Walid F Gellad; Jennifer S Haas; Dana Gelb Safran
Journal:  J Gen Intern Med       Date:  2007-09-20       Impact factor: 5.128

5.  Health insurance affects the use of disease-modifying therapy in multiple sclerosis.

Authors:  Guoqiao Wang; Ruth Ann Marrie; Amber R Salter; Robert Fox; Stacey S Cofield; Tuula Tyry; Gary R Cutter
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

6.  Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions.

Authors:  Moupali Das-Douglas; Elise D Riley; Kathleen Ragland; David Guzman; Richard Clark; Margot B Kushel; David R Bangsberg
Journal:  AIDS Behav       Date:  2008-05-16

7.  Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage.

Authors:  Linda Simoni-Wastila; Ilene H Zuckerman; Thomas Shaffer; Christopher M Blanchette; Bruce Stuart
Journal:  Health Serv Res       Date:  2008-04       Impact factor: 3.402

Review 8.  Impediments to adherence to post myocardial infarction medications.

Authors:  Nihar R Desai; Niteesh K Choudhry
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

9.  Income-, education- and gender-related inequalities in out-of-pocket health-care payments for 65+ patients - a systematic review.

Authors:  Sandro Corrieri; Dirk Heider; Herbert Matschinger; Thomas Lehnert; Elke Raum; Hans-Helmut König
Journal:  Int J Equity Health       Date:  2010-08-11

10.  Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies.

Authors:  Niteesh K Choudhry; Troyen Brennan; Michele Toscano; Claire Spettell; Robert J Glynn; Mark Rubino; Sebastian Schneeweiss; Alan M Brookhart; Joaquim Fernandes; Susan Mathew; Blake Christiansen; Elliott M Antman; Jerry Avorn; William H Shrank
Journal:  Am Heart J       Date:  2008-06-06       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.